I'm just responding to your claim that there is a delay due to lack of funding. This is absolutely incorrect.
Once again, note the guidance from the company relating to the staggered nature of activation. This is generally how multi-site trials work and is how the stage 2 pre-validation trial worked with Liverpool, Royal Melbourne & PA. Also, note Vintage's post above quoting the company is actively pursuing non dilutive federal and state funding opportunities.
EMV Price at posting:
$1.71 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)